SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

29 Jan 2024 Evaluate
Revenue showed a marginal decline at Rs. 958.19 millions. For the quarter ended December 2023, as compared to corresponding quarter of last year.Net profit declined -26.48% to Rs. 48.30 millions from Rs. 65.70 millions.Operating Profit reported a sharp decline to 122.83 millions from 150.60 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 958.19 1003.16 -4.48 2480.86 2920.83 -15.06 3965.31 3294.94 20.35
Other Income 11.06 24.21 -54.32 31.59 57.32 -44.89 64.31 45.06 42.72
PBIDT 122.83 150.60 -18.44 278.37 418.71 -33.52 576.20 424.40 35.77
Interest 16.96 16.16 4.95 46.47 43.05 7.94 55.75 83.06 -32.88
PBDT 105.87 134.44 -21.25 231.90 375.66 -38.27 520.45 341.34 52.47
Depreciation 35.78 35.57 0.59 109.55 115.51 -5.16 161.28 148.37 8.70
PBT 70.09 98.87 -29.11 122.35 260.15 -52.97 359.17 192.97 86.13
TAX 21.79 33.17 -34.31 33.71 81.47 -58.62 109.09 62.84 73.60
Deferred Tax 8.80 14.81 -40.58 12.53 34.87 -64.07 46.30 28.84 60.54
PAT 48.30 65.70 -26.48 88.64 178.68 -50.39 250.08 130.13 92.18
Equity 487.26 487.26 0.00 487.26 487.26 0.00 487.26 162.42 200.00
PBIDTM(%) 12.82 15.01 -14.61 11.22 14.34 -21.73 14.53 12.88 12.81

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×